𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical impact of assay of estrogen receptor βcx in breast cancer

✍ Scribed by Shigehira Saji; Yoko Omoto; Chikako Shinizu; Shin-ichiro Horiguchi; Toru Watanabe; Nobuaki Funata; Shin-ichi Hayashi; Jan-Åke Gustafsson; Masakazu Toi


Publisher
Springer Japan
Year
2002
Tongue
English
Weight
712 KB
Volume
9
Category
Article
ISSN
1340-6868

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Analysis of the potential contribution o
✍ J.P. Brouillet; M.A. Dujardin; D. Chalbos; J.M. Rey; J. Grenier; P.J. Lamy; T. M 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 84 KB 👁 2 views

Estrogen receptor (ER) content is the most useful parameter for predicting hormone response therapy in breast cancer. Assays available for detecting ER in breast tumor cytosol are ligand-binding assay (LBA), which detects both ER␣ and ER␤, and the enzymatic immunoassay (EIA), in which monoclonal ant